Indian Pharma companies
INDIAN PHARMA COMPANIES NEWS
Donald Trump's new pharma order could increase pressure on India to hike drug prices, stocks tank on margin worries
May 13, 2025 9:31 am
Trump said he would introduce a “most favoured nation” (MFN) policy whereby the US pays “the same price as the nation that pays the lowest price anywhere in the World".
ED attaches assets worth nearly Rs 80 crore in bank fraud case against pharma company
January 27, 2025 7:01 pm
According to the ED, the total attachment and seizure in the money laundering case against Sharon Bio-Medicine has now reached Rs 96.20 crore.
Indian pharma industry to log in 8-10% revenue growth this fiscal: Crisil
September 11, 2023 2:12 pm
A study of 186 drug makers, which accounted for about half of the Rs 3.7 lakh crore annual revenue of the sector last fiscal, indicates as much, Crisil said on Monday.
Indian firm used toxic industrial-grade ingredient in syrup: Report
June 28, 2023 8:59 am
The company, Marion Biotech, bought the ingredient — propylene glycol (PG) — from trader Maya Chemtech India, as reported by Reuters. But Maya did not have a licence to sell pharmaceutical-grade materials and "dealt in industrial-grade only."
‘Quality, safety issues continue to haunt top firms in India’
June 22, 2018 12:16 am
Numerous cases of data falsification, lax adherence to norms, says report
Draft Pharmaceutical Policy 2017: ‘Recognising drug quality concerns in India signals paradigm shift’
August 29, 2017 2:56 am
After years of constant denial, it appears that in the draft policy, the government is finally ready to accept that there is a problem with the drugs that are manufactured and sold in India. The Draft Pharmaceutical Policy 2017, prepared by the Department of Pharmaceuticals, has an entire paragraph dedicated to the quality concerns that affect the domestic market.
USFDA observations: To improve report cards, comprehensive reforms must for domestic drugmakers
August 29, 2017 2:55 am
While Sun Pharma and Glenmark Pharma submitted detailed responses that includes revising standard operating procedures and re-training employees to the USFDA to deal with its adverse observations, others have begun course-correction
US 'not targeting' Indian pharma companies, says FDA chief
February 22, 2014 11:39 am
While allaying apprehensions that the US is not targeting Indian companies, they said its a routine inspection followed across countries.
Banbaxy: Country's largest pharma firm on a slippery slope
February 02, 2014 10:37 am
Before Toansa, its three other plants in India had already been blacklisted by the FDA. (Photo: Reuters)
Pharma FDI: Non-compete clause only in special cases
January 09, 2014 4:56 pm
DIPP had proposed a slew of measures to revamp FDI policy for the sector.
Best of Express
